MONUMENT ADVOCACY for PHRMA
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues related to intellectual property protection, enforcement, and market access within trade negotiations; supply chain management; China; Issues related to global health; and issues related to tariffs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY ELLIS | — |
| RICH THOMAS | — |
Foreign Relations FOR
Issues related to intellectual property protection, enforcement, and market access within trade negotiations; supply chain management; China; issues related to global health; and issues related to tariffs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIMBERLY ELLIS | — |
| RICH THOMAS | — |
Health Issues HCR
Medicare Part D, Medicare Part B Issues, Importation of Drugs; H.R. 1, the One Big Beautiful Bill Act; H.R. 1492, S. 832, the EPIC Act; Medicare IRA implementation, Drug Premium Stabilization Program. Drug pricing, reimbursement and coverage related to MFN including CMMI models, 340B, IRA maximum fair price, ASP. PBM Reform included in H.R. 7194, the Consolidated Appropriations Act, the Department of Labor proposed PBM rule. Affordability and patient access issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOEL WHITE New | Staff Director, Ways & Means Health Subcommittee; L.A. for Rep. Jim Greenwood; L.A. for Rep. Chris Shays |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.